CoSense ETCO Monitor

Target SDGs

Target Users (Target Impact Group)

Small and Medium-sized Enterprises, Public Sector Agencies

Distributors / Implementing Organizations

Capnia, Inc. and Healthware Private Limited (in India)

Regions

Worldwide

Countries

United States

Manufacturing/Building Method

Unknown

Intellectural Property Type

Select Type

User Provision Model

Waiting for response from the manufacturer

Distributions to Date Status

Unknown

Design Specifications

The CoSense^® ETCO Monitor uses Sensalyze^™ Technology which enables the health practitioners to examine the blood pressure of an infant using non-invasive procedure. The device uses a breath sample as the patient breathes normally (typically in about 30 seconds). Once the monitor obtains a breath sample, the Precision Sampling Set can be removed from the patient. The monitor displays the results in about three to four minutes.

Technical Support

Provided by manufacturer

Replacement Components

Replaceable components include the battery.

Lifecycle

Unknown

Manufacturer Specified Performance Parameters

The designer specified performance targets include portable, accurate, and accessible with a non-invasive procedure.

Vetted Performance Status

Testing proved linear correlation CoSense®ETCO and COHb indicating accurate detection of hemolysis.

Safety

Users must take appropriate precautions when collecting the breath sample suing tubing in the nostrils.

Complementary Technical Systems

A reliable power source is required for the operation of the monitor.

Academic Research and References

Compliance with regulations

CoSense has 510(k) clearance for sale in the U.S. and has received CE Mark certification for sale in the European Union.

Evaluation methods

Multiple clinical trials for the treatment of allergies as well as pain conditions (such as migraine) have been completed using this technology.

Other Information

None